Aortic dose constraints when reirradiating thoracic tumors
Open Access
- 31 March 2013
- journal article
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 106 (3), 327-332
- https://doi.org/10.1016/j.radonc.2013.02.002
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic reviewRadiotherapy and Oncology, 2012
- Stereotactic body radiation therapy in the treatment of multiple primary lung cancersRadiotherapy and Oncology, 2012
- Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapyRadiotherapy and Oncology, 2011
- Chest Reirradiation With External Beam Radiotherapy for Locally Recurrent Non-Small-Cell Lung Cancer: A ReviewInternational Journal of Radiation Oncology*Biology*Physics, 2011
- Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II studyRadiotherapy and Oncology, 2008
- Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lungBrachytherapy, 2008
- Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Hypofractionated external beam radiotherapy as retreatment for symptomatic non–small-cell lung carcinoma: an effective treatment?International Journal of Radiation Oncology*Biology*Physics, 2004
- Tolerance of normal rabbit femoral arteries to single high dose external beam irradiationCardiovascular Radiation Medicine, 1999
- Rupture of major vessels after radiationCancer, 1975